These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 16282337)
1. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Lin YW; Nichols RA; Letterio JJ; Aplan PD Blood; 2006 Mar; 107(6):2540-3. PubMed ID: 16282337 [TBL] [Abstract][Full Text] [Related]
2. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1. Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065 [TBL] [Abstract][Full Text] [Related]
3. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195 [TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Lin YW; Aplan PD Leukemia; 2007 Jun; 21(6):1276-84. PubMed ID: 17429429 [TBL] [Abstract][Full Text] [Related]
6. NOTCH1 mutation can be an early, prenatal genetic event in T-ALL. Eguchi-Ishimae M; Eguchi M; Kempski H; Greaves M Blood; 2008 Jan; 111(1):376-8. PubMed ID: 17901244 [TBL] [Abstract][Full Text] [Related]
7. NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis. Göthert JR; Brake RL; Smeets M; Dührsen U; Begley CG; Izon DJ Blood; 2007 Nov; 110(10):3753-62. PubMed ID: 17698635 [TBL] [Abstract][Full Text] [Related]
8. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice. Mantha S; Ward M; McCafferty J; Herron A; Palomero T; Ferrando A; Bank A; Richardson C Leuk Res; 2007 Mar; 31(3):321-7. PubMed ID: 16870249 [TBL] [Abstract][Full Text] [Related]
10. K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors. Kindler T; Cornejo MG; Scholl C; Liu J; Leeman DS; Haydu JE; Fröhling S; Lee BH; Gilliland DG Blood; 2008 Oct; 112(8):3373-82. PubMed ID: 18663146 [TBL] [Abstract][Full Text] [Related]
11. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433 [TBL] [Abstract][Full Text] [Related]
12. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation. Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656 [TBL] [Abstract][Full Text] [Related]
13. p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis. Fasseu M; Aplan PD; Chopin M; Boissel N; Bories JC; Soulier J; von Boehmer H; Sigaux F; Regnault A Blood; 2007 Oct; 110(7):2610-9. PubMed ID: 17507663 [TBL] [Abstract][Full Text] [Related]
14. Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL? Goldshtein A; Berger M Crit Rev Oncog; 2014; 19(5):399-404. PubMed ID: 25404153 [TBL] [Abstract][Full Text] [Related]
15. Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development. Wang Q; Yan R; Pinnell N; McCarter AC; Oh Y; Liu Y; Sha C; Garber NF; Chen Y; Wu Q; Ku CJ; Tran I; Serna Alarcon A; Kuick R; Engel JD; Maillard I; Cierpicki T; Chiang MY Blood; 2018 Sep; 132(12):1279-1292. PubMed ID: 30076146 [TBL] [Abstract][Full Text] [Related]
16. Notch1 is a frequent mutational target in chemically induced lymphoma in mouse. Karlsson A; Ungerbäck J; Rasmussen A; French JE; Söderkvist P Int J Cancer; 2008 Dec; 123(11):2720-4. PubMed ID: 18798262 [TBL] [Abstract][Full Text] [Related]
17. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas. Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044 [TBL] [Abstract][Full Text] [Related]
18. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Pear WS; Aster JC Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998 [TBL] [Abstract][Full Text] [Related]
19. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes. Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630 [TBL] [Abstract][Full Text] [Related]
20. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]